Clinical Trial Update: Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating metyrosine (Demser) for psychotic disorders in patients with Velocardiofacial syndrome; trial terminated with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis
• Velocardiofacial Syndrome

Drugs mentioned

• METYROSINE (Metyrosine)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Velo-cardio-facial Syndrome, Psychosis | Phase 2 | Status: TERMINATED | Results posted: 2018-05-08